Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.
Citations
Altmetric
Author
Prentice, RE; Tjandra, D; Garg, M; Lubel, JS; Fourlanos, S; Johnson, D; Al-Ani, A; Christensen, BDate
2020-10Source Title
Alimentary Pharmacology and TherapeuticsAffiliation
Medical EducationMedicine and Radiology
Metadata
Show full item recordDocument Type
Journal ArticleCitations
Prentice, R. E., Tjandra, D., Garg, M., Lubel, J. S., Fourlanos, S., Johnson, D., Al-Ani, A. & Christensen, B. (2020). Letter: ACE2, IBD and COVID-19-why IBD patients may be at reduced risk of COVID-19.. Aliment Pharmacol Ther, 52 (8), pp.1422-1423. https://doi.org/10.1111/apt.16063.Access Status
Access this item via the Open Access locationOpen Access URL
https://europepmc.org/articles/PMC7537250?pdf=renderOpen Access at PMC
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7537250Export Reference in RIS Format
Endnote
- Click on "Export Reference in RIS Format" and choose "open with... Endnote".
Refworks
- Click on "Export Reference in RIS Format". Login to Refworks, go to References => Import References